Johnson M A, Anderson J P, Stevens L M. "Method for the Synthesis of 1-(1-(2-Methoxyethyl)-1H-indol-3-yl)-3-(pyridin-2-ylmethyl)urea" [P]. US Patent, US 10036613 B2, 2017-12-02.
发明人高志强,周伟,何建平. "A Process for Preparing High-Purity 1-(1-(2-Methoxyethyl)-1H-indol-3-yl)-3-(pyridin-2-ylmethyl)urea" [P]. 中国发明专利, 专利号 CN 112365515 B, 授权公告日 2017-08-18.
参考文献 Literature
Hughes D, Roberts J, Thomas A. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 635, 4219-4223.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2012, 2035, (3), 8889-8892.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of 1-(1-(2-Methoxyethyl)-1H-indol-3-yl)-3-(pyridin-2-ylmethyl)urea Using HRMS and NMR". Anal. Methods, 2014, 1203, (10), 6830-6844.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2014, 1763, (4), 919-934.